on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Present at Emerging Growth Conference
Jaguar Health, Inc. (NASDAQ:JAGX) announced that its founder, president, and CEO, Lisa Conte, will deliver a virtual presentation at the Emerging Growth Conference on June 18, 2025. The event will focus on updates and near-term catalysts for the company.
This conference presentation will be available online from 9:40 to 10:10 AM Eastern Time, with a replay accessible on EmergingGrowth.com and the Emerging Growth YouTube Channel. Jaguar Health, a pharmaceutical company, emphasizes developing plant-based proprietary medicines targeting gastrointestinal distress for humans and animals.
Napo Pharmaceuticals, a Jaguar subsidiary, offers crofelemer for noninfectious diarrhea in adults with HIV/AIDS. Meanwhile, Napo Therapeutics, established in Milan, works to expand crofelemer's reach in Europe. Magdalena Biosciences, a joint venture with Filament Health Corp., aims to develop plant-derived medicines for mental health.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news